Company Filing History:
Years Active: 2025
Title: Katherine Ann Vousden: Innovator in FcγRIIA-Binding Molecules
Introduction
Katherine Ann Vousden is a prominent inventor based in Cambridgeshire, GB. She has made significant contributions to the field of biomedical research, particularly in the development of molecules that target specific receptors involved in immune responses.
Latest Patents
Katherine holds a patent for "Binding molecules specific for FcγRIIA and uses thereof." This patent describes FcγRIIA-binding molecules, including humanized monoclonal antibodies that can inhibit FcγRIIA activity. The methods outlined in her patent are aimed at treating or preventing inflammatory, immune-mediated, or autoimmune diseases and disorders.
Career Highlights
Katherine is currently associated with Horizon Therapeutics Ireland DAC, where she continues to advance her research and development efforts. Her work has the potential to impact the treatment of various immune-related conditions.
Collaborations
Katherine has collaborated with notable colleagues, including Bo Chen and Gary Patrick Sims, to further her research initiatives and enhance the effectiveness of her inventions.
Conclusion
Katherine Ann Vousden is a trailblazer in the field of immunology, with her innovative work on FcγRIIA-binding molecules paving the way for new therapeutic approaches. Her contributions are vital in addressing complex immune-mediated disorders.